PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Uncategorized
Harrow plans to acquire Melt Pharmaceuticals
Harrow entered into an agreement to acquire Melt Pharmaceuticals and plans to submit a new drug application for MELT-300, Melt’s lead candidate, to the FDA in 2027.“MELT-300 integrates seamlessly into Harrow’s existing commercial infrastructure, specif…
Uncategorized
Visible family-friendly resources increase women resident numbers
CHICAGO — Orthopedic surgery residency programs with family-friendly resources listed on the program and Graduate Medical Education websites had a higher proportion of women residents, according to results presented here.“While not all of our findings …
Uncategorized
Ten things doctors wish their administrators would do differently
“It doesn’t matter whether you are pursuing success in business, sports, the arts or life in general: The bridge between wishing and accomplishing is discipline.”– Harvey Mackay“Our prime purpose in this life is to help others. And if you can’t help th…
Neurotech Granted Permanent J-Code (J3403) for ENCELTO™ (revakinagene taroretcel-lwey), Effective October 1, 2025
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, today announced that the Centers for Medicare & Medicaid Services (CMS) has assig…
AR Breakthrough: SCHOTT achieves serial production of Geometric Reflective Waveguides
RYE BROOK, N.Y.–(BUSINESS WIRE)–International technology group SCHOTT, a leader in high-performance materials and optics, has achieved a breakthrough in high-volume production of Geometric Reflective Waveguides. This marks a key advancement for Augme…